WO1996021434A1 - Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze - Google Patents
Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze Download PDFInfo
- Publication number
- WO1996021434A1 WO1996021434A1 PCT/EP1996/000074 EP9600074W WO9621434A1 WO 1996021434 A1 WO1996021434 A1 WO 1996021434A1 EP 9600074 W EP9600074 W EP 9600074W WO 9621434 A1 WO9621434 A1 WO 9621434A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- form according
- net
- methyl
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE59611212T DE59611212D1 (de) | 1995-01-14 | 1996-01-10 | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze |
EP96900309A EP0802790B1 (de) | 1995-01-14 | 1996-01-10 | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze |
BR9607488A BR9607488A (pt) | 1995-01-14 | 1996-01-10 | Um sistema terapêutico transdérmico para a administração de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol ou um dos seus sais farmaceuticamente aceítaveis |
JP8521426A JPH10511972A (ja) | 1995-01-14 | 1996-01-10 | (s)−3−メチル−5−(1−メチル−2−ピロリデニル)−イソオキサゾールまたはその製薬上受け入れられる塩類の一つの投与のための経皮性治療系 |
AT96900309T ATE292458T1 (de) | 1995-01-14 | 1996-01-10 | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2- pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze |
AU43911/96A AU719171B2 (en) | 1995-01-14 | 1996-01-10 | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts |
NZ298428A NZ298428A (en) | 1995-01-14 | 1996-01-10 | Transdermal system to dispense (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol or salt thereof |
MXPA/A/1997/005324A MXPA97005324A (en) | 1995-01-14 | 1997-07-14 | Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19501022.1 | 1995-01-14 | ||
DE19501022A DE19501022C1 (de) | 1995-01-14 | 1995-01-14 | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996021434A1 true WO1996021434A1 (de) | 1996-07-18 |
Family
ID=7751534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/000074 WO1996021434A1 (de) | 1995-01-14 | 1996-01-10 | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0802790B1 (de) |
JP (1) | JPH10511972A (de) |
KR (1) | KR19980701419A (de) |
AR (1) | AR001070A1 (de) |
AT (1) | ATE292458T1 (de) |
BR (1) | BR9607488A (de) |
CA (1) | CA2210341A1 (de) |
DE (2) | DE19501022C1 (de) |
IL (1) | IL116615A (de) |
NZ (1) | NZ298428A (de) |
WO (1) | WO1996021434A1 (de) |
ZA (1) | ZA96260B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004258A1 (en) * | 1996-07-25 | 1998-02-05 | Smithkline Beecham Plc | Formulation for the treatment and/or prophylaxis of dementia |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10004790B4 (de) * | 2000-02-01 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung |
DE10019067C1 (de) * | 2000-04-18 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung |
DE10118282A1 (de) | 2001-04-12 | 2002-12-05 | Lohmann Therapie Syst Lts | Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025025A2 (de) * | 1993-04-28 | 1994-11-10 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Systeme zur kontrollierten abgabe von pilocarpin |
WO1994026257A1 (de) * | 1993-05-06 | 1994-11-24 | Lts Lohmann Therapie-Systeme Gmbh | Estradiolhaltiges transdermales therapeutisches system |
WO1995015754A1 (en) * | 1993-12-08 | 1995-06-15 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153360T3 (es) * | 1991-05-29 | 2001-03-01 | Abbott Lab | Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento. |
-
1995
- 1995-01-14 DE DE19501022A patent/DE19501022C1/de not_active Expired - Fee Related
- 1995-12-29 IL IL11661595A patent/IL116615A/xx not_active IP Right Cessation
-
1996
- 1996-01-10 AT AT96900309T patent/ATE292458T1/de not_active IP Right Cessation
- 1996-01-10 KR KR1019970704809A patent/KR19980701419A/ko active IP Right Grant
- 1996-01-10 BR BR9607488A patent/BR9607488A/pt not_active Application Discontinuation
- 1996-01-10 EP EP96900309A patent/EP0802790B1/de not_active Expired - Lifetime
- 1996-01-10 JP JP8521426A patent/JPH10511972A/ja not_active Ceased
- 1996-01-10 CA CA002210341A patent/CA2210341A1/en not_active Abandoned
- 1996-01-10 NZ NZ298428A patent/NZ298428A/en unknown
- 1996-01-10 WO PCT/EP1996/000074 patent/WO1996021434A1/de active IP Right Grant
- 1996-01-10 DE DE59611212T patent/DE59611212D1/de not_active Expired - Fee Related
- 1996-01-12 ZA ZA96260A patent/ZA96260B/xx unknown
- 1996-01-12 AR AR33502496A patent/AR001070A1/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025025A2 (de) * | 1993-04-28 | 1994-11-10 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Systeme zur kontrollierten abgabe von pilocarpin |
WO1994026257A1 (de) * | 1993-05-06 | 1994-11-24 | Lts Lohmann Therapie-Systeme Gmbh | Estradiolhaltiges transdermales therapeutisches system |
WO1995015754A1 (en) * | 1993-12-08 | 1995-06-15 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
Non-Patent Citations (2)
Title |
---|
KANG ET AL: "transdermal abt-418: pharmacokinetic and pharmacodynamic properties of a cholinergic channel activator", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 20, no. 1-2, 13 November 1994 (1994-11-13), pages 174, XP000564993 * |
Y. W. CHIEN: "Development of transdermal drug delivery sytems", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 13, no. 4&5, pages 589 - 651 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004258A1 (en) * | 1996-07-25 | 1998-02-05 | Smithkline Beecham Plc | Formulation for the treatment and/or prophylaxis of dementia |
Also Published As
Publication number | Publication date |
---|---|
JPH10511972A (ja) | 1998-11-17 |
IL116615A (en) | 1999-09-22 |
CA2210341A1 (en) | 1996-07-18 |
DE19501022C1 (de) | 1996-06-05 |
IL116615A0 (en) | 1996-03-31 |
ATE292458T1 (de) | 2005-04-15 |
EP0802790B1 (de) | 2005-04-06 |
DE59611212D1 (de) | 2005-05-12 |
KR19980701419A (ko) | 1998-05-15 |
BR9607488A (pt) | 1997-12-23 |
AR001070A1 (es) | 1997-09-24 |
NZ298428A (en) | 1999-10-28 |
ZA96260B (en) | 1996-08-01 |
EP0802790A1 (de) | 1997-10-29 |
MX9705324A (es) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0889723B1 (de) | Transdermales therapeutisches system mit geringer applikationsdicke und hoher flexibilität sowie herstellungsverfahren | |
EP0377147B1 (de) | Transdermales therapeutisches System mit Physostigmin als wirksamem Bestandteil und Verfahren zu seiner Herstellung | |
EP0288734B1 (de) | Wirkstoffhaltiges Pflaster zur kontrollierten Verabreichung von Wirkstoffen an die Haut | |
WO1987006144A1 (en) | Planar therapeutic system, process for its production and its utilization | |
DD241853A5 (de) | Verfahren zur herstellung eines pharmazeutischen produktes | |
EP0387694B1 (de) | Pflaster als therapeutisches System zur Verabreichung von Wirkstoffen an die Haut mit einer abgestuften Wirkstoffabgabe, Verfahren zu seiner Herstellung sowie Verwendung | |
WO1988001516A1 (en) | Transdermal therapeutic system, its use and production process | |
EP0298297A1 (de) | Transdermales therapeutisches System | |
DE60311449T2 (de) | Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen | |
EP1855660A1 (de) | Faserfreies transdermales therapeutisches system und verfahren zu seiner herstellung | |
DE3908431C2 (de) | ||
EP1220661B1 (de) | Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure | |
EP0948363A1 (de) | Extrem flexibles, dermal oder transdermal wirkendes pflaster und verfahren zu seiner herstellung | |
EP1251853B1 (de) | Transdermales therapeutisches system zur verabreichung von zaleplon | |
EP0374725B1 (de) | Transdermales therapeutisches System mit Norpseudoephedrin als aktivem Bestandteil | |
DE19501022C1 (de) | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung | |
WO1999056734A2 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
EP3145501B1 (de) | Lavendelöl enthaltendes transdermales therapeutisches system | |
EP0742716B1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
DE19949252B4 (de) | Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung | |
WO1994005295A1 (de) | Transdermales therapeutisches system mit pentylentetrazol als wirkstoff | |
AU719171B2 (en) | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts | |
MXPA97005324A (en) | Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap | |
DD279404A5 (de) | Flaechenfoermiges, therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA JP KR MX NZ SI US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996900309 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2210341 Country of ref document: CA Kind code of ref document: A Ref document number: 2210341 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/005324 Country of ref document: MX Ref document number: 1019970704809 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 298428 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1996900309 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970704809 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970704809 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996900309 Country of ref document: EP |